{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:20:09Z","timestamp":1793625609395,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2025YFA0922400"],"award-info":[{"award-number":["2025YFA0922400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900987"],"award-info":[{"award-number":["81900987"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2025AFB729"],"award-info":[{"award-number":["2025AFB729"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mtbio.2026.103645","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:15:29Z","timestamp":1788538529000},"page":"103645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A transdermal CRISPR\/Cas9 strategy using biodegradable microneedles to target YB-1 in melanoma"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2738-5233","authenticated-orcid":false,"given":"Xiazhou","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0675-6338","authenticated-orcid":false,"given":"Jingwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103645_bib1","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1038\/s41467-025-60160-2","article-title":"Selective targeting of genome amplifications and repeat elements by CRISPR-Cas9 nickases to promote cancer cell death","volume":"16","author":"Hanlon","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103645_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111917","article-title":"CRISPR: history and perspectives to the future","volume":"141","author":"Kozovska","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mtbio.2026.103645_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jconrel.2021.08.007","article-title":"Versatile modification of the CRISPR\/Cas9 ribonucleoprotein system to facilitate in vivo application","volume":"337","author":"Sun","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.mtbio.2026.103645_bib4","article-title":"CRISPR\/Cas9 systems: delivery technologies and biomedical applications","volume":"18","author":"Du","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.mtbio.2026.103645_bib5","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","article-title":"Therapeutic in vivo delivery of gene editing agents","volume":"185","author":"Raguram","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2026.103645_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","article-title":"CRISPR\/Cas9 therapeutics: progress and prospects","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.mtbio.2026.103645_bib7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/nano15070540","article-title":"Precisely targeted nanoparticles for CRISPR-Cas9 delivery in clinical applications","volume":"15","author":"Liu","year":"2025","journal-title":"Nanomaterials"},{"key":"10.1016\/j.mtbio.2026.103645_bib8","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1021\/acs.nanolett.4c00533","article-title":"A Guanidinobenzol-Rich polymer overcoming Cascade delivery barriers for CRISPR-Cas9 genome editing","volume":"24","author":"Liang","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2026.103645_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.mtbio.2026.103645_bib10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s12272-024-01514-0","article-title":"Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition","volume":"47","author":"Lo","year":"2024","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.mtbio.2026.103645_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2022.02.035","article-title":"Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing","volume":"345","author":"Chae","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.mtbio.2026.103645_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.phrs.2010.03.005","article-title":"Targeting nanoparticles to cancer","volume":"62","author":"Wang","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mtbio.2026.103645_bib13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s11095-006-0028-9","article-title":"Polymer microneedles for controlled-release drug delivery","volume":"23","author":"Park","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mtbio.2026.103645_bib14","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.biomaterials.2007.12.048","article-title":"Dissolving microneedles for transdermal drug delivery","volume":"29","author":"Lee","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2026.103645_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2018.183","article-title":"Non-invasive delivery strategies for biologics","volume":"18","author":"Anselmo","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2026.103645_bib16","doi-asserted-by":"crossref","first-page":"14952","DOI":"10.1021\/acsami.4c20844","article-title":"Microneedle-Mediated synergistic photothermal and chemotherapy for targeted melanoma treatment","volume":"17","author":"Zhang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2026.103645_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","article-title":"Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems","volume":"22","author":"Baryakova","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2026.103645_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1884","article-title":"Microneedle\u2010assisted transdermal delivery of nanoparticles: recent insights and prospects","volume":"15","author":"Guillot","year":"2023","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.103645_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe2888","article-title":"Microneedle-assisted genome editing: a transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders","volume":"7","author":"Wan","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2026.103645_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/s12916-022-02614-8","article-title":"Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapy","volume":"20","author":"Cheng","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.mtbio.2026.103645_bib21","first-page":"1267","article-title":"Enhanced siRNA delivery using oleic acid derivative of polyethylenimine","author":"Teng","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mtbio.2026.103645_bib22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.apsb.2019.06.004","article-title":"Development and application of hyaluronic acid in tumor targeting drug delivery","volume":"9","author":"Luo","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103645_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119305","article-title":"Chondroitin Sulfate: emerging biomaterial for biopharmaceutical purpose and tissue engineering","volume":"286","author":"Sharma","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.mtbio.2026.103645_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1054-3589(05)53003-5","article-title":"Structure of chondroitin sulfate","volume":"53","author":"Lamari","year":"2006","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.mtbio.2026.103645_bib25","doi-asserted-by":"crossref","first-page":"9125","DOI":"10.1039\/D2TB01514E","article-title":"Chondroitin sulfate-based composites: a tour d'horizon of their biomedical applications","volume":"10","author":"Abourehab","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.mtbio.2026.103645_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103836","article-title":"Tumor-Microenvironment-responsive nanomedicine for enhanced cancer immunotherapy","volume":"9","author":"Peng","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.mtbio.2026.103645_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.colsurfb.2019.02.031","article-title":"Chondroitin sulfate-functionalized polymeric nanoparticles for colon cancer-targeted chemotherapy","volume":"177","author":"Zu","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.mtbio.2026.103645_bib28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/cdd.2013.13","article-title":"Targeting the Y\/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?","volume":"20","author":"Dolfini","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mtbio.2026.103645_bib29","first-page":"623","article-title":"Connection of intracellular protein YB-1 localization in cell cultures of human tumors with multidrug resistance","volume":"59","author":"Eiu","year":"2013","journal-title":"Vopr. Onkol."},{"key":"10.1016\/j.mtbio.2026.103645_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejcb.2013.11.007","article-title":"Y-box binding protein - a prognostic marker and target in tumour therapy","volume":"93","author":"Kosnopfel","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.mtbio.2026.103645_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BJ20121323","article-title":"YB-1: Oncoprotein, prognostic marker and therapeutic target?","volume":"449","author":"Lasham","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.mtbio.2026.103645_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ccr.2009.03.017","article-title":"Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition","volume":"15","author":"Evdokimova","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mtbio.2026.103645_bib33","first-page":"S20","article-title":"YB-1 Structure\/function relationship in the packaging of mRNPs and consequences for translation regulation and stress granule assembly in cells","volume":"87","author":"Hamon","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.mtbio.2026.103645_bib34","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.bjc.6602987","article-title":"Expression of Y-box-binding protein dbpC\/contrin, a potentially new cancer\/testis antigen","volume":"94","author":"Kohno","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mtbio.2026.103645_bib35","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s00066-023-02092-8","article-title":"YB-1 activating cascades as potential targets in KRAS-mutated tumors","volume":"199","author":"Khozooei","year":"2023","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.mtbio.2026.103645_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12951-025-03523-7","article-title":"Transdermal delivery of CRISPR\/Cas9-mediated melanoma gene therapy via polyamines-modified thermosensitive hydrogels","volume":"23","author":"Li","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.mtbio.2026.103645_bib37","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103645_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.actbio.2022.08.026","article-title":"Dynamic ginsenoside-sheltered nanocatalysts for safe ferroptosis-apoptosis combined therapy","volume":"151","author":"Zhao","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2026.103645_bib39","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin - an agent with multiple mechanisms of anticancer activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.mtbio.2026.103645_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","article-title":"Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction","volume":"36","author":"Koblan","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mtbio.2026.103645_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117964","article-title":"Co-encapsulation of collagenase type I and silibinin in chondroitin sulfate coated multilayered nanoparticles for targeted treatment of liver fibrosis","volume":"263","author":"Luo","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.mtbio.2026.103645_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140316","article-title":"Fabrication and characterization of teriflunomide-loaded chondroitin sulfate hybridized zein nanoparticles for the management of triple negative breast cancer","volume":"300","author":"Rajana","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2026.103645_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5021\/ad.2019.31.3.349","article-title":"Regional variation of human skin surface temperature","volume":"31","author":"Lee","year":"2019","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.mtbio.2026.103645_bib44","doi-asserted-by":"crossref","first-page":"35936","DOI":"10.1021\/acsami.4c03171","article-title":"Chondroitin sulfate derivative cross-linking of decellularized heart valve for the improvement of mechanical properties, hemocompatibility, and endothelialization","volume":"16","author":"Yan","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2026.103645_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138793","article-title":"Shark chondroitin sulfate gold nanoparticles: a biocompatible apoptotic agent for osteosarcoma","volume":"290","author":"Vijayakumar","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2026.103645_bib46","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.3390\/pharmaceutics14112537","article-title":"Combination of nanovectorized siRNA directed against survivin with Doxorubicin for efficient anti-cancer activity in HER2+ breast cancer cells","volume":"14","author":"Eljack","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103645_bib47","article-title":"Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy","volume":"5","author":"Dheeraj","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.mtbio.2026.103645_bib48","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/carcin\/bgt155","article-title":"Survivin promotion of melanoma metastasis requires upregulation of \u03b15 integrin","volume":"34","author":"McKenzie","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mtbio.2026.103645_bib49","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jid.2025.11.015","article-title":"E-Cadherin, MITF, and phenotypic plasticity in melanoma: a crossroads between cell adhesion, differentiation, and hormonal regulation","volume":"146","author":"Larue","year":"2026","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.mtbio.2026.103645_bib50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejps.2017.09.019","article-title":"Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer","volume":"116","author":"Gunasekaran","year":"2018","journal-title":"Eur J Pharm Sci"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426008902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426008902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:32:41Z","timestamp":1790335961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426008902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":50,"alternative-id":["S2590006426008902"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103645","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A transdermal CRISPR\/Cas9 strategy using biodegradable microneedles to target YB-1 in melanoma","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103645"}}